Prucka 3 Amplifier Model #P1801PA used with CardioLab AltiX electrophysiology recording system and ComboLab AltiX hemodynamic and electrophysiology recording system; and Field Replacement Units spare part #5875569 (Assy CLABIII AMP 128CH 100-240V 50-60HZ).
This recall is currently active, issued July 3, 2024. It was issued by Ge Medical Systems Information Technologies Inc.
- Recall Initiated
- April 22, 2024
- Posted
- July 3, 2024
- Recall Number
- Z-2258-2024
- Quantity
- 145 units
- Firm Location
- Milwaukee, WI
- Official Source
- View on FDA website ↗
Reason for Recall
Capacitors in certain Prucka 3 Amplifiers used with CardioLab / ComboLab systems could fail resulting in transient oscillations on the display and inability to view surface and intracardiac ECG waveforms.
Distribution
Worldwide - US Nationwide distribution in the states of AK, AZ, CA, CO, FL, GA, IL, KY, MA, ME, MN, MO, NC, NJ, NY, OH, OR, PA, TN, TX, and WA. The countries of Belgium, Canada, Czech Republic, France, Germany, Ireland, Israel, Italy, Japan, Republic of Korea, and Singapore.
Lot / Code Info
UDI N/A for the Prucka 3 Amplifier-not a medical device. CardioLab and ComboLab Systems GTIN #00195278507044 and #00195278507051. Prucka 3 Amplifier serial numbers: SVS23400020SA, SVS23400024SA, SVS23360017SA, SVS23400003SA, SVS23470003SA, SVS23350005SA, SVS23330008SA, SVS23350001SA, SVS23350003SA, SVS23360018SA, SVS23520022SA, SVS23350008SA, SVS23280009SA, SVS23350021SA, SVS23470016SA, SVS23470010SA, SVS23360013SA, SVS23280002SA, SVS23400026SA, SVS23400039SA, SVS23400021SA, SVS23330006SA, SVS23360014SA, SVS23360016SA, SVS23460020SA, SVS23470022SA, SVS23480007SA, SVS23360010SA, SVS23350024SA, SVS24020002SA, SVS24020004SA, SVS24020005SA, SVS24020006SA, SVS24020007SA, SVS24020011SA, SVS23460002SA, SVS23350004SA, SVS23350006SA, SVS23350007SA, SVS23480003SA, SVS23400008SA, SVS23210005SA, SVS23360007SA, SVS23360002SA, SVS23360012SA, SVS23470004SA, SVS23520018SA, SVS23520020SA, SVS24020016SA, SVS23460001SA, SVS23470006SA, SVS23470008SA, SVS23350002SA, SVS23350009SA, SVS23350025SA, SVS23360003SA, SVS23360005SA, SVS23360006SA, SVS23360011SA, SVS23400023SA, SVS23400030SA, SVS23400031SA, SVS23400032SA, SVS23400037SA, SVS23400038SA, SVS23460007SA, SVS23400015SA, SVS23350011SA, SVS23350017SA, SVS23470017SA, SVS23470018SA, SVS23470020SA, SVS23460013SA, SVS23460014SA, SVS23480002SA, SVS23480005SA, SVS23480010SA, SVS23480011SA, SVS23480013SA, SVS23480015SA, SVS23520012SA, SVS23280008SA, SVS23290004SA, SVS23330004SA, SVS23350014SA, SVS23350022SA, SVS23350023SA, SVS23460006SA, SVS23400022SA, SVS23350012SA, SVS23350016SA, SVS23480004SA, SVS23470007SA, SVS23400025SA, SVS23460003SA, SVS23460004SA, SVS23350015SA, SVS23320002SA, SVS23470013SA, SVS23350020SA, SVS23330005SA, SVS23470009SA, SVS23470011SA, SVS23470019SA, SVS23470012SA, SVS23460016SA, SVS23290001SA, SVS23350013SA, SVS23460017SA, SVS23480012SA, SVS23480016SA, SVS23330007SA, SVS23360008SA, SVS23360020SA, SVS23400005SA, SVS23400009SA, SVS23400010SA, SVS23400019SA, SVS23460008SA, SVS23280005SA, SVS23400004SA, SVS23460005SA, SVS23400034SA, SVS23400035SA, SVS23400036SA, SVS23400033SA, SVS23400018SA, SVS23470005SA, SVS23400028SA, SVS23400029SA, SVS23360019SA, SVS23400002SA, SVS23360004SA, SVS23400007SA, SVS23400011SA, SVS23400006SA, SVS23350018SA, SVS23330003SA, SVS23290003SA, SVS23290002SA, SVS23330009SA, SVS23350019SA, SVS23360015SA, SVS23470001SA, and SVS23470002SA.
Root Cause
Process control
Action Taken
The recalling firm issued letters on and dated 4/22/2024 via traceable means informing the consignee of the affected product details, safety issue, and actions to be taken by the customer/user. The consignee was informed they can continue to use the Prucka 3 Amplifiers with the CardioLab/ComboLab systems with the following conditions: (1) Ensure additional devices are immediately available to monitor surface and intracardiac ECG waveforms in order to complete the study (e.g. patient monitor, 3D mapping system, etc.) until the device is corrected; (2) In the event the Prucka 3 Amplifier malfunction occurs during the case with the loss of ECG waveforms, use an alternate device; (3) Ensure the hospital staff are familiar with utilizing the Direct Stimulator Connections on the CIM Block(s). This allows pacing from the stimulator if the amplifier is not functioning properly. The consignee is to ensure all potential users in the facility are made aware of this safety notification and the recommended actions. An acknowledgment form was enclosed for completion and return no later than 30 days from receipt of the letter. GE HealthCare will correct all affected devices and a representative will contact the consignee to arrange for the correction.